This reference inhibitor is a Food and Drug Administration (FDA) and European Medicines Agency (EMA)-approved reference medication against obesity that inhibits pancreatic lipase. The gene discussed is PNLIP; the disease is obesity due to melanocortin 4 receptor deficiency.